6505--Zonisamide Capsules

The solicitation requires offerors to develop detailed subcontracting goals, providing justification whenever a proposed goal is lower than the VA‑suggested target or the prior year’s achievement, and to document the specific methods used to identify potential small‑business sources (e.g., websites, associations, events). Offerors must submit separate 11‑digit National Drug Code (NDC) numbers for each drug product, meet the packaging requirements outlined in the Scope of Contract, and price all line items for the base year plus four option years, including a mandatory .50 % Cost Recovery Fee. The proposal must include complete subcontracting plans (individual and/or commercial) that incorporate all indirect costs, state dollar and percentage goals for each option period, and demonstrate good‑faith efforts to provide equitable opportunities to small, veteran‑owned, HUBZone, disadvantaged, and women‑owned businesses. Offerors must also complete the representations and provisions in FAR 52.209‑7, 52.219‑1, 52.204‑24, and 52.225‑6, and provide authorized negotiator information. In addition, the contract mandates quarterly sales reporting of all contract sales in U.S. dollars, with collection of the Cost Recovery Fee, and requires a letter of commitment from any non‑manufacturing offeror confirming sufficient supply from the manufacturer. Detailed facility information—including location, ownership, and FDA Establishment Identification numbers—for all pharmaceutical ingredients, sterilization, packaging, and final product sites must be provided. The acceptance period for offers is extended to 120 calendar days, and multiple offers are permitted when the solicitation is awarded by group or line item. Failure to include any required information may result in delay or rejection of the offer.

Notice ID

b4814d124eb2431daccfe412f47152e0

Solicitation Number

36E79726R0005

NAICS Code

325412

Classification Code

6505